These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 13799992)

  • 1. Effects of certain vitamins and histamines on the LSD psychosis.
    BERTINO JR; KLEE GD; WEINTRAUB W
    J Ment Sci; 1959 Oct; 105():1095-9. PubMed ID: 13799992
    [No Abstract]   [Full Text] [Related]  

  • 2. ELECTROENCEPHALOGRAPHIC EFFECTS OF LSD, AND SOME PSYCHIATRIC IMPLICATIONS.
    WERRE PF
    J Neuropsychiatr; 1964 Dec; 5():516-24. PubMed ID: 14246552
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INFLUENCE OF LSD-25 RESEARCH ON AN ALCOHOLIC PSYCHOSIS.
    BENTON AJ
    Am J Psychiatry; 1964 Mar; 120():907-8. PubMed ID: 14129295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antipheine and its effects on the course of LSD psychoses].
    VINAR O
    Act Nerv Super (Praha); 1961 May; 3():211-2. PubMed ID: 13926054
    [No Abstract]   [Full Text] [Related]  

  • 5. [Similarities and dissimilarities of experimental psychoses caused by LSD-25 and mescaline].
    VOJTECHOVSKY M; GROF S
    Cesk Psychiatr; 1960 Aug; 56():221-33. PubMed ID: 13781932
    [No Abstract]   [Full Text] [Related]  

  • 6. Some test findings associated with susceptibility to psychosis induced by lysergic acid diethylamide.
    PAUK ZD; SHAGASS C
    Compr Psychiatry; 1961 Aug; 2():188-95. PubMed ID: 14484460
    [No Abstract]   [Full Text] [Related]  

  • 7. THE USE OF LYSERGIC ACID DIETHYLAMIDE (LSD) IN PSYCHOTHERAPY.
    BAKER EF
    Can Med Assoc J; 1964 Dec; 91(23):1200-2. PubMed ID: 14226093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some related factors of the LSD 25 reaction.
    SALVATORE S
    Psychiatr Q; 1960 Apr; 34():236-51. PubMed ID: 13745802
    [No Abstract]   [Full Text] [Related]  

  • 9. [EFFECT OF NICOTINIC ACID ON EXPERIMENTAL PSYCHOSES INDUCED WITH LYSERGIC ACID DIETHYLAMIDE].
    IVANOVA RA; MILSHTEIN GI; SMIRNOVA LB; FANCHENKO ND
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1172-6. PubMed ID: 14244572
    [No Abstract]   [Full Text] [Related]  

  • 10. [Model psychoses and lysergic acid diethylamide treatment].
    GEERT-JORGENSEN E
    Ugeskr Laeger; 1961 Oct; 123():1452-5. PubMed ID: 13897484
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of syndromes under LSD-25.
    van REE F
    Fortschr Psychosom Med; 1960; 1():209-12. PubMed ID: 14436858
    [No Abstract]   [Full Text] [Related]  

  • 12. PSYCHOPATHOLOGY OF LSD INTOXICATION; STUDY OF EXPERIMENTAL PSYCHOSIS INDUCED BY LSD-25: DESCRIPTION OF LSD SYMPTOMS IN NORMAL ORIENTAL SUBJECTS.
    KURAMOCHI H; TAKAHASHI R
    Arch Gen Psychiatry; 1964 Aug; 11():151-61. PubMed ID: 14237611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary notes on the use of LSD 25 in the production of experimental psychoses].
    FRAGOSO MENDES J
    Med Contemp; 1956 Dec; 74(12):565-70. PubMed ID: 13386654
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE VARIABILITY OF THE EFFECT OF DRUGS (PARTICULARLY WITH RESPECT TO THE EFFECT AND HAZARDS OF LSD ADMINISTRATION)].
    DRVOTA S
    Act Nerv Super (Praha); 1963 May; 5():217-8. PubMed ID: 14073987
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the LSD-25 experience and delirium tremens.
    DITMAN KS; WHITTLESEY JR
    AMA Arch Gen Psychiatry; 1959 Jul; 1():47-57. PubMed ID: 13816944
    [No Abstract]   [Full Text] [Related]  

  • 16. [A LSD-25 CLINICO-EXPERIMENTAL TEST AS AN ACCESSORY MEASURE IN DIFFERENTIAL DIAGNOSIS OF PSYCHOSES AND SIMULATED MENTAL DISORDERS].
    TEMKOV I; BOIADZHIEVA M
    Suvr Med (Sofiia); 1964; 15():28-34. PubMed ID: 14273246
    [No Abstract]   [Full Text] [Related]  

  • 17. New blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Science; 1955 Feb; 121(3137):208-10. PubMed ID: 13237971
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental compound mer-17 (frenquel): a new blocking agent against the development of LSD-25 psychosis.
    FABING HD
    Trans Am Neurol Assoc; 1955-1956; (80th Meeting):83-5. PubMed ID: 13312008
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of group administration upon symptom formation under LSD.
    SLATER PE; MORIMOTO K; HYDE RW
    J Nerv Ment Dis; 1957; 125(2):312-5. PubMed ID: 13481730
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive vitamin treatment in some neuritides and some psychoses.
    VINER N
    Can Med Assoc J; 1950 Feb; 62(2):162-4. PubMed ID: 15409423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.